"But I noted concern it's taken ages to recruit people for the...

"But I noted concern it's taken ages to recruit people for the trial..."

Recruitment was very slow but has increased significantly.

One could argue that that increase is due to noticeable improvements seen by medical staff of those on the trial.

If it was the other way around I would be concerned. This way it is one of those little indicators that can point to trial success.

The product is cheap, non-invasive and easy to use. If it leads to improvements like we have seen before than ftt have a very attractive commercial product imho.

I do think investor sentiment will turn as we get nearer to trial completion. If not then afterwards (assuming success, which seems likely but not definite).

cheers